Dabur India expands product portfolio with launch of nutraceuticals
The launch of Siens aligns with Dabur’s revamped growth strategy, which is expected to be achieved by FY28.
INDIA – Dabur, an Indian multinational consumer goods company, has entered the nutraceuticals segment with the launch of its new wellness brand, Siens, marking a significant expansion of its product portfolio into the premium health and nutrition space.
The collection includes marine collagen, 3-in-1 hair, skin, and nail gummies, multivitamins tailored for both men and women, Omega-3 softgels, and daily pre- and probiotics.
It features a range of contemporary formats, including gummies, softgels, and tablets.
Siens delivers targeted wellness solutions across three core categories: beauty and skin health, daily wellness, and gut health.
All products are formulated with clinically studied ingredients sourced from globally reputed suppliers and manufactured in GMP-, ISO-, and HACCP-certified facilities.
Mr. Pratyush Gupta, Head of Customer Marketing at Dabur India Limited, stated, “Siens is a future-ready wellness brand born out of Dabur’s legacy of trust and our deep understanding of evolving consumer expectations.”
“Wellness today is no longer about vague promises; it’s about precision, evidence, and experience. That’s what Siens delivers.”
According to the company, Siens is founded on formulations developed with clinically tested ingredients, carefully sourced for quality, and backed by over 141 years of consumer trust through its parent company, the House of Dabur.
This launch follows the company’s recent announcement of a strategic exit from several non-performing product categories, including Vedic tea, diapers, breakfast cereals, sanitisers, and its malted food drink brand, Vita.
The decision is part of a broader portfolio restructuring aimed at accelerating profitable growth and achieving double-digit revenue and profit growth by the end of fiscal year 2028.
Speaking during a post-earnings conference call, Dabur India CEO Mohit Malhotra stated that these product segments have been margin-dilutive and collectively account for less than 1% of the company’s overall revenue.
The fast-moving consumer goods (FMCG) company has also unveiled a seven-point strategy to drive growth, including continued investment in core brands, a focus on premiumisation and modernisation across categories, bold bets in health and wellness, consolidation of distribution in metro areas, expansion into quick commerce, and aggressive mergers and acquisitions.
The company aims to build a future-ready portfolio that resonates with younger consumers, particularly in the areas of healthcare, wellness foods, and premium personal care.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
